Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Older and new purine nucleoside analogs for patients with acute leukemias.

Robak P, Robak T.

Cancer Treat Rev. 2013 Dec;39(8):851-61. doi: 10.1016/j.ctrv.2013.03.006. Epub 2013 Apr 6. Review.

PMID:
23566572
2.

Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.

Robak T, Lech-Maranda E, Korycka A, Robak E.

Curr Med Chem. 2006;13(26):3165-89.

PMID:
17168705
3.

Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.

Robak T, Robak P.

Curr Pharm Des. 2012;18(23):3373-88. Review.

PMID:
22591387
4.

Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.

Robak T, Korycka A, Kasznicki M, Wrzesien-Kus A, Smolewski P.

Curr Cancer Drug Targets. 2005 Sep;5(6):421-44. Review.

PMID:
16178817
5.

Novel purine nucleoside analogues for hematological malignancies.

Korycka A, Lech-Marańda E, Robak T.

Recent Pat Anticancer Drug Discov. 2008 Jun;3(2):123-36. Review.

PMID:
18537755
6.

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

Robak T, Korycka A, Lech-Maranda E, Robak P.

Molecules. 2009 Mar 23;14(3):1183-226. doi: 10.3390/molecules14031183. Review.

7.

Purine nucleoside analogues in the treatment of myleoid leukemias.

Robak T.

Leuk Lymphoma. 2003 Mar;44(3):391-409. Review.

PMID:
12688309
8.

Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.

Larson RA.

Semin Oncol. 2007 Dec;34(6 Suppl 5):S13-20. Review.

PMID:
18086342
9.

Clofarabine and nelarabine: two new purine nucleoside analogs.

Gandhi V, Plunkett W.

Curr Opin Oncol. 2006 Nov;18(6):584-90. Review.

PMID:
16988579
10.

New nucleoside analogs for patients with hematological malignancies.

Robak T.

Expert Opin Investig Drugs. 2011 Mar;20(3):343-59. doi: 10.1517/13543784.2011.554822. Review.

PMID:
21320002
11.
12.

Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.

Lech-Maranda E, Korycka A, Robak T.

Mini Rev Med Chem. 2006 May;6(5):575-81. Review.

PMID:
16719832
13.

Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application.

Korycka A, Błoński JZ, Robak T.

Mini Rev Med Chem. 2007 Sep;7(9):976-83. Review.

PMID:
17897085
14.

Clofarabine.

[No authors listed]

Drugs R D. 2004;5(4):213-7. Review.

PMID:
15230627
15.

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.

Wrzesień-Kuś A, Robak T, Wierzbowska A, Lech-Marańda E, Pluta A, Wawrzyniak E, Krawczyńska A, Kuliczkowski K, Mazur G, Kiebiński M, Dmoszyńska A, Wach M, Hellmann A, Baran W, Hołowiecki J, Kyrcz-Krzemień S, Grosicki S; Polish Adult Leukemia Group.

Ann Hematol. 2005 Sep;84(9):557-64. Epub 2005 Apr 27.

PMID:
15856358
16.

Nelarabine: a novel purine antimetabolite antineoplastic agent.

Buie LW, Epstein SS, Lindley CM.

Clin Ther. 2007 Sep;29(9):1887-99. Review.

PMID:
18035189
17.
18.

New nucleoside analogs in the treatment of hematological disorders.

Szafraniec SI, Stachnik KJ, Skierski JS.

Acta Pol Pharm. 2004 May-Jun;61(3):223-32. Review.

19.
20.

Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies.

Robak T, Korycka A, Robak E.

Recent Pat Anticancer Drug Discov. 2006 Jan;1(1):23-38. Review.

PMID:
18221024

Supplemental Content

Support Center